N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism

Autor: Brendan Harhen, Bright N. Okine, Manish K. Madasu, David P. Finn, Charles Prendergast, Jessica C. Gaspar, Michelle Roche, Fiona McGowan
Přispěvatelé: Science Foundation Ireland, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil, College of Science, National University of Ireland, Galway
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Male
PREFRONTAL CORTEX
Cohort Studies
Rats
Sprague-Dawley

chemistry.chemical_compound
0302 clinical medicine
Receptor
Cannabinoid
CB1

Pain Measurement
ESCAPE/AVOIDANCE BEHAVIOR
Chemistry
Central nucleus of the amygdala
Anti-Inflammatory Agents
Non-Steroidal

NEUROPATHIC PAIN
food and beverages
Endocannabinoid system
medicine.anatomical_structure
Neurology
Ethanolamines
lipids (amino acids
peptides
and proteins)

Diterpenes
Microdissection
Proto-Oncogene Proteins c-fos
Locomotion
psychological phenomena and processes
medicine.drug
AM251
medicine.medical_specialty
NOXIOUS STIMULI
Microinjections
TRPV1
Pain
Palmitic Acids
RAT-BRAIN
Gyrus Cinguli
03 medical and health sciences
Fixatives
Internal medicine
Formaldehyde
medicine
Animals
FATTY-ACID AMIDE
Cannabinoid Receptor Antagonists
CANNABINOID RECEPTOR
Palmitoylethanolamide
Amides
Rats
PPAR gamma
AMYGDALA
MODEL
Disease Models
Animal

030104 developmental biology
Anesthesiology and Pain Medicine
Endocrinology
ANANDAMIDE
nervous system
Cannabinoid receptor antagonist
Neurology (clinical)
Rostral ventromedial medulla
Neuroscience
030217 neurology & neurosurgery
Basolateral amygdala
Popis: The neural substrates and mechanisms mediating the antinociceptive effects of the endogenous bioactive lipid, N-palmitoylethanolamide (PEA), require further investigation. We investigated the effects of exogenous PEA administration into the anterior cingulate cortex (ACC), an important brain region linked with cognitive and affective modulation of pain, on formalin-evoked nociceptive behaviour in rats. Potential involvement of peroxisome proliferator-activated receptor isoforms (PPAR) a and g or endocannabinoid-mediated entourage effects at cannabinoid(1) (CB1) receptors or transient receptor potential subfamily V member 1 (TRPV1) in mediating the effects of PEA was also investigated. Intra-ACC administration of PEA significantly attenuated the first and early second phases of formalin-evoked nociceptive behaviour. This effect was attenuated by the CB1 receptor antagonist AM251, but not by the PPAR alpha antagonist GW6471, the PPAR gamma antagonist GW9662, or the TRPV1 antagonist 5'-iodo resiniferatoxin. All antagonists, administered alone, significantly reduced formalin-evoked nociceptive behaviour, suggesting facilitatory/permissive roles for these receptors in the ACC in inflammatory pain. Post-mortem tissue analysis revealed a strong trend for increased levels of the endocannabinoid anandamide in the ACC of rats that received intra-ACC PEA. Expression of c-Fos, a marker of neuronal activity, was significantly reduced in the basolateral nucleus of the amygdala, but not in the central nucleus of the amygdala, the rostral ventromedial medulla or the dorsal horn of the spinal cord. In conclusion, these data indicate that PEA in the ACC can reduce inflammatory pain-related behaviour, possibly via AEA-induced activation of CB1 receptors and associated modulation of neuronal activity in the basolateral amygdala. This work was funded by a Principal Investigator Programme Grant from Science Foundation Ireland (10/IN.1/B2976), a PhD fellowship to JCG from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil (207530/2014-9), and a PhD Fellowship to MKM from the College of Science, NUI Galway. peer-reviewed
Databáze: OpenAIRE